As the world continues to grapple with the ongoing COVID-19 pandemic, new questions have emerged about the origin of the virus and whether one of its more pathogenic variants, Delta, may have originated from Pfizer Inc.'s India operations.
“Promise you won’t tell anyone. The way [the experiment] would work is that we put the virus in monkeys, and we successively cause them to keep infecting each other, and we collect serial samples from them," the Pfizer executive says.
"I believe we should stop trying to prevent all symptomatic infections in healthy, young people by boosting them with vaccines containing mRNA from strains that might disappear a few months later," writes doctor.
Less than a month after the CDC marked the two-year anniversary of the first administered COVID-19 vaccine by telling Americans to get a bivalent booster, two peer-reviewed German studies have found that mRNA vaccines — the vast majority of the U.S. market — induce worse antibodies compared to traditional adenovirus vaccines.